Involvement of ERK and AKT signaling in the growth effect of arginine vasopressin on adult rat cardiac fibroblast and the modulation by simvastatin

Molecular and Cellular Biochemistry

Volumn 317, Issue 1-2, 2008, Pages 33-41

  He, Yan Ping ^a   Zhao, Lian You ^a   Zheng, Qiang Sun ^a   Liu, Shao Wei ^a   Zhao, Xiao Yan ^a   Lu, Xiao Long ^a   Niu, Xiao Lin ^a   Li, Xia ^b  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b INSTITUTE OF AVIATION MEDICINE   (China)

Author keywords

AKT; Arginine vasopressin; Extracellular signal regulated kinase 1 2; Phosphatidylinositol 3 kinase; Protein kinase C; Statins

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 MORPHOLINO 8 PHENYLCHROMONE; ARGIPRESSIN; MITOGEN ACTIVATED PROTEIN KINASE 1; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; PROTEIN KINASE B INHIBITOR; SIMVASTATIN;

ANIMAL CELL; ARTICLE; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; DNA SYNTHESIS INHIBITION; DRUG ACTIVITY; FIBROBLAST; HEART FIBROBLAST; HORMONE ACTION; NONHUMAN; RAT; SIGNAL TRANSDUCTION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; ARGININE VASOPRESSIN; CELL PROLIFERATION; DNA; ENZYME ACTIVATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FIBROBLASTS; MALE; MEVALONIC ACID; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MYOCARDIUM; PROTEIN KINASE C; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION; SIMVASTATIN;

RATTUS;

EID: 53149152203     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-008-9802-9     Document Type: Article

References (31)

1. Cohn JN, Ferrari R, Sharpe N (2000) Cardiac remodeling-concepts and clinical implications: A consensus paper from an international forum on cardiac remodeling. Behalf of an International Forum on Cardiac Remodeling. J Am Coll Cardiol 35:569-582. doi: 10.1016/ S0735-1097(99)00630-0
2. Weber KT, Brilla CG, Janicki JS (1993) Myocardial fibrosis: Functional significance and regulatory factors. Cardiovasc Res 27:341-348. doi: 10.1093/cvr/27.3.341
3. Yang F, Liu YH, Yang XP et al (2002) Myocardial infarction and cardiac remodelling in mice. Exp Physiol 87:547-555. doi: 10.1113/eph8702385
4. Naitoh M, Suzuki H, Murakami M et al (1994) Effects of oral AVP receptor antagonists OPC-21268 and OPC-31260 on congestive heart failure in conscious dogs. Am J Physiol 267:H2245-H2254
5. Uretsky BF, Verbalis JG, Generalovich T et al (1985) Plasma vasopressin response to osmotic and hemodynamic stimuli in heart failure. Am J Physiol 248:H396-H402
6. Kawano Y, Matsuoka H, Nishikimi T et al (1997) The role of vasopressin in essential hypertension. Plasma levels and effects of the V1 receptor antagonist OPC-21268 during different dietary sodium intakes. Am J Hypertens 10:1240-1244. doi: 10.1016/S0895-7061(97)00269-0
7. Chatterjee K (2005) Neurohormonal activation in congestive heart failure and the role of vasopressin. Am J Cardiol 95:8B-13B. doi: 10.1016/ j.amjcard.2005.03.003
8. Nakamura Y, Haneda T, Osaki J et al (2000) Hypertrophic growth of cultured neonatal rat heart cells mediated by vasopressin V(1A) receptor. Eur J Pharmacol 391:39-48. doi: 10.1016/S0014-2999(99)00775-X
9. Fukuzawa J, Haneda T, Kikuchi K (1999) Arginine vasopressin increases the rate of protein synthesis in isolated perfused adult rat heart via the V1 receptor. Mol Cell Biochem 195:93-98. doi: 10.1023/A:1006980517557
10. Tahara A, Tomura Y, Wada K et al (1998) Effect of YM087, a potent nonpeptide vasopressin antagonist, on vasopressin-induced protein synthesis in neonatal rat cardiomyocyte. Cardiovasc Res 38:198-205. doi: 10.1016/S0008-6363(97)00324-6
11. Lee TM, Lin MS, Chou TF et al (2005) Effect of simvastatin on left ventricular mass in hypercholesterolemic rabbits. Am J Physiol Heart Circ Physiol 288:H1352-H1358. doi: 10.1152/ajpheart.00527.2003
12. Luo JD, Zhang WW, Zhang GP et al (1999) Simvastatin inhibits cardiac hypertrophy and angiotensin-converting enzyme activity in rats with aortic stenosis. Clin Exp Pharmacol Physiol 26:903-908. doi: 10.1046/ j.1440-1681.1999.03165.x
13. Loch D, Levick S, Hoey A et al (2006) Rosuvastatin attenuates hypertension-induced cardiovascular remodeling without affecting blood pressure in DOCA-salt hypertensive rats. J Cardiovasc Pharmacol 47:396-404
14. Dechend R, Fiebeler A, Park JK et al (2001) Amelioration of angiotensin II-induced cardiac injury by a 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor. Circulation 104:576-581. doi: 10.1161/hc3001.092039
15. Tian JW, Zhao LY, Wang SW et al (2003) Effects of atorvastatin on the proliferation and collagen synthesis of rat cardiac fibroblasts. Zhonghua Yi Xue Za Zhi 83:118-122
16. Moiseeva OM, Semyonova EG, Polevaya EV et al (2007) Effect of pravastatin on phenotypical transformation of fibroblasts and hypertrophy of cardiomyocytes in culture. Bull Exp Biol Med 143:54-57. doi: 10.1007/s10517-007-0015-0
17. Yang XD, Zhao LY, Zheng QS et al (2003) Effects of arginine vasopressin on growth of rat cardiac fibroblasts: Role of V1 receptor. J Cardiovasc Pharmacol 42:132-135. doi: 10.1097/00005344-200307000-00020
18. Lazou A, Bogoyevitch MA, Clerk A et al (1994) Regulation of mitogen-activated protein kinase cascade in adult rat heart preparations in vitro. Circ Res 75:932-941
19. Chiu T, Wu SS, Santiskulvong C et al (2002) Vasopressin-mediated mitogenic signaling in intestinal epithelial cells. Am J Physiol Cell Physiol 282:C434-C450
20. Chen D, Fong HW, Davis JS (2001) Induction of c-fos and c-jun messenger ribonucleic acid expression by prostaglandin F2{{alpha}} is mediated by a protein kinase C-dependent extracellular signal-regulated kinase mitogen-activated protein kinase pathway in bovine luteal cells. Endocrinology 142:887-895. doi: 10.1210/en.142.2.887
21. Tahara A, Tsukada J, Tomura Y et al (2007) Effect of YM218, a nonpeptide vasopressin V(1A) receptor-selective antagonist, on rat mesangial cell hyperplasia and hypertrophy. Vascul Pharmacol 46:463-469. doi: 10.1016/ j.vph.2007.02.001
22. Bhora FY, Kothary PC, Imanishi H et al (1994) Vasopressin stimulates DNA synthesis in cultured rat hepatocytes. J Surg Res 57:706-710. doi: 10.1006/jsre.1994.1205
23. Lagumdzija A, Pernow Y, Bucht E et al (2005) The effects of arg-vasopressin on osteoblast-like cells in endothelial nitric oxide synthase-knockout mice and their wild type counterparts. Peptides 26:1661-1666. doi: 10.1016/j.peptides.2005.02.007
24. Xu YJ, Ouk Kim S, Liao DF et al (2000) Stimulation of 90- and 70-kDa ribosomal protein S6 kinases by arginine vasopressin and lysophosphatidic acid in rat cardiomyocytes. Biochem Pharmacol 59:1163-1171. doi: 10.1016/S0006-2952(00)00239-2
25. Aharonovitz O, Aboulafia-Etzion S, Leor J et al (1998) Stimulation of 42/ 44 kDa mitogen-activated protein kinases by arginine vasopressin in rat cardiomyocytes. Biochim Biophys Acta (BBA) Mol Cell Res 1401:105-111
26. Daub H, Wallasch C, Lankenau A et al (1997) Signal characteristics of G protein-transactivated EGF receptor. EMBO J 16:7032-7044. doi: 10.1093/ emboj/16.23.7032
27. Zimmermann S, Moelling K (1999) Phosphorylation and regulation of Raf by Akt (protein kinase B). Science 286:1741-1744. doi: 10.1126/ science.286.5445.1741
28. Cross DA, Alessi DR, Vandenheede JR et al (1994) The inhibition of glycogen synthase kinase-3 by insulin or insulin-like growth factor 1 in the rat skeletal muscle cell line L6 is blocked by wortmannin, but not by rapamycin: Evidence that wortmannin blocks activation of the mitogen-activated protein kinase pathway in L6 cells between Ras and Raf. Biochem J 303(Pt 1):21-26
29. Rommel C, Clarke BA, Zimmermann S et al (1999) Differentiation stage-specific inhibition of the Raf-MEK-ERK pathway by Akt. Science 286:1738-1741. doi: 10.1126/science.286.5445.1738
30. Ferby IM, Waga I, Hoshino M et al (1996) Wortmannin inhibits mitogen-activated protein kinase activation by platelet-activating factor through a mechanism independent of p85/p110-type phosphatidylinositol 3-kinase. J Biol Chem 271:11684-11688. doi: 10.1074/ jbc.271.20.11684
31. Denhardt DT (1996) Signal-transducing protein phosphorylation cascades mediated by Ras/Rho proteins in the mammalian cell: The potential for multiplex signaling. Biochem J 318(Pt 3):729-747